Neurocrine Biosciences (NBIX) Revenue by Segment

History

Date	Ingrezza	Ongentys and Other Products	Collaboration and Other
Sep 30, 2025	2.47B	19.80M	25.90M
Jun 30, 2025	2.40B	18.30M	26.40M
Mar 31, 2025	2.35B	18.20M	27.30M
Dec 31, 2024	2.31B	17.20M	24.70M
Sep 30, 2024	2.20B	18.00M	26.20M
Jun 30, 2024	2.07B	20.40M	27.70M
Mar 31, 2024	1.93B	22.70M	27.70M
Dec 31, 2023	1.84B	24.60M	26.50M
Sep 30, 2023	1.74B	23.00M	25.90M
Jun 30, 2023	1.63B	19.80M	27.50M
Mar 31, 2023	1.54B	15.60M	47.30M
Dec 31, 2022	1.43B	13.10M	47.80M
Sep 30, 2022	1.33B	10.20M	48.90M
Jun 30, 2022	1.24B	9.60M	47.50M
Mar 31, 2022	1.15B	9.20M	43.40M
Dec 31, 2021	1.08B	8.20M	43.40M
Sep 30, 2021	1.02B	6.60M	41.50M
Jun 30, 2021	988.80M	4.40M	38.70M
Mar 31, 2021	991.60M	-	51.40M

Source: Business metrics provided by Main Street Data and sourced from official company press releases and documents.